Clovis Oncology, Inc. Deferred Tax Assets, Gross
Clovis Oncology, Inc. had Deferred Tax Assets, Gross of $878.66 million as of 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2022-02-24
- 2021-12-31: Deferred Tax Assets, Gross $878.66M.
- 2020-12-31: Deferred Tax Assets, Gross $813.70M.
- 2019-12-31: Deferred Tax Assets, Gross $757.34M.
- 2018-12-31: Deferred Tax Assets, Gross $649.64M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2021-12-31 | $878.66M 10-K · filed 2022-02-24 |
| 2020-12-31 | $813.70M 10-K · filed 2022-02-24 |
| 2019-12-31 | $757.34M 10-K · filed 2021-02-25 |
| 2018-12-31 | $649.64M 10-K · filed 2020-02-26 |
| 2017-12-31 | $565.38M 10-K · filed 2019-02-28 |
| 2016-12-31 | $593.64M 10-K · filed 2018-02-27 |
| 2015-12-31 | $463.06M 10-K · filed 2017-02-23 |
| 2014-12-31 | $264.29M 10-K · filed 2016-02-29 |
| 2013-12-31 | $139.16M 10-K · filed 2015-02-27 |
| 2012-12-31 | $91.69M 10-K · filed 2014-02-28 |
| 2011-12-31 | $55.87M 10-K · filed 2013-03-14 |